Technology | Catheters | November 09, 2016

Merit Medical Receives 510(k) Clearance for SwiftNINJA Steerable Microcatheter

Straight-tip catheter designed to reach inaccessible areas for coronary and peripheral applications

Merit Medical Systems, SwiftNINJA Steerable Microcatheter, FDA 510(k) clearance

November 9, 2016 — Merit Medical Systems Inc. announced that it has received 510(k) clearance for the SwiftNINJA Steerable Microcatheter. The clearance covers peripheral and coronary applications. With the exception of Japan, Merit has global distribution rights for the SwiftNINJA.

The SwiftNINJA Steerable Microcatheter is a straight-tip cathter that articulates up to 180 degrees in opposing directions to rapidly select the most challenging vascular ostium. It offers 3-D steering with one-handed operation and is designed to reach otherwise inaccessible areas.

The device is scheduled to be launched simultaneously with the Corvocet Biopsy System, which also received 510(k) clearance recently.

For more information: www.merit.com


Related Content

News | Cath Lab

May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...

Home May 13, 2026
Home
News | Cath Lab

April 16, 2026 — A national study led by investigators from Cedars-Sinai Health Sciences University found that ...

Home April 20, 2026
Home
News | Cath Lab

April 6, 2026 —Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its Synchrony system ...

Home April 07, 2026
Home
News | Cath Lab

March 31, 2026 — Solo Pace Inc. has announced the commercial release of the SoloPace Fusion Temporary Pacing System. The ...

Home April 03, 2026
Home
News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
Subscribe Now